José Luis ORDOÑEZ-LIBRADO et al. L-DOPA/Capsazepine or L-DOPA/Rimonabant Co-Administration in an Experimental Parkinson Disease Model: Behavioral and Cellular Consequences. Issues and Developments in Medicine and Medical Research Vol. 5, [S. l.], p. 35–60, 2022. DOI: 10.9734/bpi/idmmr/v5/2361C. Disponível em: https://stm.bookpi.org/IDMMR-V5/article/view/5580. Acesso em: 17 jun. 2026.